Emerald Health Therapeutics Inc
F:TBD
Emerald Health Therapeutics Inc
Note Receivable
Emerald Health Therapeutics Inc
Note Receivable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Note Receivable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Emerald Health Therapeutics Inc
F:TBD
|
Note Receivable
CA$406k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Canopy Growth Corp
TSX:WEED
|
Note Receivable
CA$107.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Note Receivable
$20.8m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Note Receivable
CA$45.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Emerald Health Therapeutics Inc
Glance View
Emerald Health Therapeutics, Inc. operates as a cannabis company. The company is headquartered in Vancouver, British Columbia and currently employs 110 full-time employees. The firm's segments include Cannabis and Other. The company primarily operates in the Cannabis segment. The company provides recreational, medical and wellness-oriented cannabis products. The company offers products through brands, including SYNC Wellness, Fuse, whole-flower cannabis, Souvenir and Health Therapeutics. Its SYNC Wellness products include nanoemulsions and cannabis oils. Its Fuse product include nanoemulsion shots. Its whole-flower cannabis products consist of dried cannabis and pre-rolled cannabis. Its Souvenir product is dried flower, which is hang-dried and hand-packaged to optimize terpene profiles. Its Health Therapeutics offers medical products. Its subsidiaries include Emerald Health Therapeutics Canada Inc., Emerald Health Naturals Inc., Avalite Sciences Inc., Verdelite Sciences Inc., and Verdelite Property Holdings Inc.
See Also
What is Emerald Health Therapeutics Inc's Note Receivable?
Note Receivable
406k
CAD
Based on the financial report for Dec 31, 2021, Emerald Health Therapeutics Inc's Note Receivable amounts to 406k CAD.
